Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
C1 esterase inhibitor (human) by Octapharma for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency): Likelihood of Approval
C1 esterase inhibitor (human) is under clinical development by Octapharma and currently in Phase III for Hereditary Angioedema (HAE) (C1...
Data Insights
C1 esterase inhibitor (human) by Takeda Pharmaceutical for Acquired (Autoimmune) Hemolytic Anemia: Likelihood of Approval
C1 esterase inhibitor (human) is under clinical development by Takeda Pharmaceutical and currently in Phase II for Acquired (Autoimmune) Hemolytic...